Bill Few Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bill Few Associates's LLY Position: Q3 2026 in Review
Bill Few Associates reduced its Eli Lilly (LLY) stake by 0.49% in Q3 2026, selling an estimated $10.6K and leaving 1,841 shares worth $2.13M. The position accounts for 0.44% of the portfolio, ranked #55.
Bill Few Associates first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.39M in Q4 2025. 1,741 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Bill Few Associates held 1,841 shares of Eli Lilly worth $2.13M as of Q3 2026.
- Bill Few Associates sold 9 Eli Lilly shares in Q3 2026, an estimated $10.6K.
- Eli Lilly made up 0.44% of Bill Few Associates's portfolio in Q3 2026, its #55 holding.
- Bill Few Associates first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- Bill Few Associates's Eli Lilly position peaked at $2.39M in Q4 2025.
- 1,741 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Bill Few Associates's 13F filing for Q3 2026, filed 9 Oct 2026.